Related Experiment Video
Updated: Jan 3, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients
Cyril Mousseaux1, Axelle Dupont2, Cédric Rafat3
1Medical Intensive Care Unit, Saint-Louis Hospital, Assistance Publique-Hopitaux de Paris, Paris Diderot University, Paris, France. mousseaux.cyril@gmail.com.
Insights
Severe hypercalcemia (HCM) is a serious condition often requiring intensive care. Prompt management, particularly with bisphosphonates, and early ICU admission are crucial for improving outcomes in HCM patients, especially those with solid tumors.
Area of Science:
- Intensive Care Medicine
- Nephrology
- Endocrinology
Background:
- Severe hypercalcemia (HCM) is a frequent reason for intensive care unit (ICU) admission.
- HCM can lead to significant morbidity and mortality, necessitating a thorough understanding of its clinical features, causes, and management.
Purpose of the Study:
- To describe the clinical and biological characteristics of severe HCM.
- To identify the etiologies, treatments, and outcomes of patients admitted to the ICU with severe HCM.
Main Methods:
- A retrospective case series analysis of patients admitted to two ICUs between January 2007 and February 2017.
- Inclusion criteria: total calcemia > 12 mg/dL (3 mmol/L).
- Data collected included clinical and biological features, etiologies, treatments, and outcomes.
Main Results:
- 131 patients with severe HCM were included.
- Hematologic malignancy (44.3%) and solid tumors (22.1%) were the most common causes.
- 82.4% of patients developed acute kidney injury (AKI), and 19% required renal replacement therapy (RRT).
- Bisphosphonate use was significantly associated with decreased calcemia at day 5.
- ICU and hospital mortality rates were 9.9% and 21.3%, respectively.
- Simplified Acute Physiologic Score (SAPS II) and underlying solid tumors were independent predictors of hospital mortality.
Conclusions:
- Severe HCM is associated with high mortality, primarily driven by underlying malignancies.
- Organ failures, such as AKI, are common but often reversible with early ICU intervention.
- Early ICU admission and prompt management are critical for improving survival, especially in patients with solid tumors and neurological symptoms.
Background:
Severe hypercalcemia (HCM) is a common reason for admission in intensive-care unit (ICU). This case series aims to describe the clinical and biological features, etiologies, treatments, and outcome associated with severe HCM. This study included all patients with a total calcemia above 12 mg/dL (3 mmol/L) admitted in two ICUs from January 2007 to February 2017.
Results:
131 patients with HCM were included. HCM was related to hematologic malignancy in 58 (44.3%), solid tumors in 29 (22.1%), endocrinopathies in 16 (12.2%), and other causes in 28 (21.3%) patients. 108 (82.4%) patients fulfilled acute kidney injury (AKI) criteria. Among them, 25 (19%) patients required renal replacement therapy (RRT). 51 (38.9%) patients presented with neurological symptoms, 73 (55.7%) patients had cardiovascular manifestations, and 50 (38.1%) patients had digestive manifestations. The use of bisphosphonates (HR, 0.42; 95% CI, 0.27-0.67; P < 0.001) was the only treatment significantly associated with a decrease of total calcemia below 12 mg/dL (3 mmol/L) at day 5. ICU and Hospital mortality rates were, respectively, 9.9% and 21.3%. Simplified Acute Physiologic Score (SAPS II) (OR, 1.05; 95% CI 1.01-1.1; P = 0.03) and an underlying solid tumor (OR, 13.83; 95% CI 2.24-141.25; P = 0.01) were two independent factors associated with hospital mortality in multivariate analysis.
Conclusions:
HCM is associated with high mortality rates, mainly due to underlying malignancies. The course of HCM may be complicated by organ failures which are most of the time reversible with early ICU management. Early ICU admission and prompt HCM management are crucial, especially in patients with an underlying solid tumor presenting with neurological symptoms.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Kidney Injury V: Interprofessional Care

